EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Maintenance and Reversibility of Paroxysmal Atrial Fibrillation in JDP2 Overexpressing Mice

Gerhild Euler iD, Jacqueline Heger, Marcel Rossol, Rainer Schulz iD, Mariana Parahuleva, Jens Kockskämper iD

Cells · 2025

DOI: 10.3390/cells14141079 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2025. Verfasst von Gerhild Euler und 5 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Physiology, Justus Liebig University, 35392 Giessen, Germany. Hauptthemen laut MEDLINE: Atrial Fibrillation, Repressor Proteins. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heart-specific overexpression of transcriptional regulator JDP2 (jun dimerization protein 2) for 5 weeks provokes paroxysmal atrial fibrillation (AF) in mice. We now investigated whether AF and atrial remodeling will be reversible upon termination of JDP2 overexpression, and whether paroxysmal AF converts to permanent AF in the presence of maintained JDP2 overexpression. Cardiac-specific JDP2 overexpression for 5 weeks, resulting in paroxysmal AF, was either continued or repressed via a tet-off system for another 5 weeks. ECGs were recorded weekly. Thereafter, heart and lung weights, and atrial mRNA and protein expression were determined. Extending JDP2 overexpression did not aggravate the AF phenotype, still paroxysmal AF, prolongation of PQ intervals, and atrial hypertrophy were present. This phenotype was completely reversible upon cessation of JDP2 overexpression. A massive downregulation of connexin40 and calcium handling proteins, including SERCA2a, calsequestrin, and ryanodine receptor, was observed in atria after prolonged JDP2 overexpression. In conclusion, atrial remodeling and paroxysmal AF under JDP2 overexpression are not sufficient to maintain or aggravate AF in the absence of JDP2. The comparison of the two groups indicates that the downregulation of calcium proteins and connexins is an important factor in the maintenance of the disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationRepressor ProteinsAnimalsMiceMice, TransgenicHeart AtriaAtrial RemodelingElectrocardiographySarcoplasmic Reticulum Calcium-Transporting ATPasesGap Junction alpha-5 ProteinMaleRyanodine Receptor Calcium Release ChannelDisease Models, Animal

Stichwörter der Autor:innen

ECGJDP2SERCA2aatrial hypertrophycalciumconnexinparoxysmal atrial fibrillationryanodine receptor

Substanzen

Repressor ProteinsSarcoplasmic Reticulum Calcium-Transporting ATPasesGap Junction alpha-5 ProteinRyanodine Receptor Calcium Release Channel

Autor:innen und Institutionen

  • Institute of Physiology, Justus Liebig University, 35392 Giessen, Germany.
  • Biochemical-Pharmacological Centre (BPC) Marburg, Institute of Pharmacology and Clinical Pharmacy, University of Marburg, 35043 Marburg, Germany.
  • Internal Medicine/Cardiology and Angiology, University Hospital of Giessen and Marburg, 35033 Marburg, Germany.

ORCID-Profile: Gerhild Euler, Rainer Schulz, Jens Kockskämper

Zitieren

APA

Euler, G., Heger, J., Rossol, M., Schulz, R., Parahuleva, M., & Kockskämper, J. (2025). Maintenance and Reversibility of Paroxysmal Atrial Fibrillation in JDP2 Overexpressing Mice. Cells. https://doi.org/10.3390/cells14141079

Vancouver

Euler G, Heger J, Rossol M, Schulz R, Parahuleva M, Kockskämper J. Maintenance and Reversibility of Paroxysmal Atrial Fibrillation in JDP2 Overexpressing Mice. Cells. 2025. doi:10.3390/cells14141079

BibTeX
@article{Euler2025,
  author = {Euler, Gerhild and Heger, Jacqueline and Rossol, Marcel and Schulz, Rainer and Parahuleva, Mariana and Kockskämper, Jens},
  title = {Maintenance and Reversibility of Paroxysmal Atrial Fibrillation in JDP2 Overexpressing Mice},
  journal = {Cells},
  year = {2025},
  doi = {10.3390/cells14141079}
}
Kostenlos starten →